208 related articles for article (PubMed ID: 21886768)
1. B cell depletion in HIV-1 subtype A infected Ugandan adults: relationship to CD4 T cell count, viral load and humoral immune responses.
Oballah P; Flach B; Eller LA; Eller MA; Ouma B; de Souza M; Kibuuka HN; Wabwire-Mangen F; Brown BK; Michael NL; Robb ML; Montefiori D; Polonis VR
PLoS One; 2011; 6(8):e22653. PubMed ID: 21886768
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression.
Chuenchitra T; Wasi C; Louisirirojchanakul S; Nitayaphan S; Sutthent R; Cox JH; De Souza MS; Brown AE; Birx DL; Polonis VR
AIDS Res Hum Retroviruses; 2003 Apr; 19(4):293-305. PubMed ID: 12804005
[TBL] [Abstract][Full Text] [Related]
3. Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy.
Hu X; Hong K; Zhao C; Zheng Y; Ma L; Ruan Y; Gao H; Greene K; Sarzotti-Kelsoe M; Montefiori DC; Shao Y
J Gen Virol; 2012 Oct; 93(Pt 10):2267-2278. PubMed ID: 22791603
[TBL] [Abstract][Full Text] [Related]
4. Highly efficient neutralization by plasma antibodies from human immunodeficiency virus type-1 infected individuals on antiretroviral drug therapy.
Andrabi R; Makhdoomi MA; Kumar R; Bala M; Parray H; Gupta A; Kotnala A; Thirumurthy V; Luthra K
J Clin Immunol; 2014 May; 34(4):504-13. PubMed ID: 24682667
[TBL] [Abstract][Full Text] [Related]
5. Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response.
Wagner GA; Landais E; Caballero G; Phung P; Kosakovsky Pond SL; Poignard P; Richman DD; Little SJ; Smith DM
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615205
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antibodies that mediate HIV type 1 gp120 antibody-dependent cell-mediated cytotoxicity in asymptomatic HIV type 1-positive men and women.
Mata MM; Iwema JR; Dell S; Neems L; Jamieson BD; Phair J; Cohen MH; Anastos K; Baum LL
AIDS Res Hum Retroviruses; 2014 Jan; 30(1):50-7. PubMed ID: 23972002
[TBL] [Abstract][Full Text] [Related]
7. Neutralization sensitivity of HIV-1 subtype B' clinical isolates from former plasma donors in China.
OuYang Y; Sun J; Huang Y; Lu L; Xu W; Hu X; Hong K; Jiang S; Shao Y; Ma L
Virol J; 2013 Jan; 10():10. PubMed ID: 23289760
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG.
Md Zahid H; Kuwata T; Takahama S; Kaku Y; Biswas S; Matsumoto K; Tamamura H; Matsushita S
Retrovirology; 2021 Aug; 18(1):23. PubMed ID: 34419098
[TBL] [Abstract][Full Text] [Related]
9. B-lymphocyte dysfunction in chronic HIV-1 infection does not prevent cross-clade neutralization breadth.
Boliar S; Murphy MK; Tran TC; Carnathan DG; Armstrong WS; Silvestri G; Derdeyn CA
J Virol; 2012 Aug; 86(15):8031-40. PubMed ID: 22623771
[TBL] [Abstract][Full Text] [Related]
10. Evolution of cross-neutralizing antibodies and mapping epitope specificity in plasma of chronic HIV-1-infected antiretroviral therapy-naïve children from India.
Makhdoomi MA; Khan L; Kumar S; Aggarwal H; Singh R; Lodha R; Singla M; Das BK; Kabra SK; Luthra K
J Gen Virol; 2017 Jul; 98(7):1879-1891. PubMed ID: 28696188
[TBL] [Abstract][Full Text] [Related]
11. Neutralization resistant HIV-1 primary isolates from antiretroviral naïve chronically infected children in India.
Makhdoomi MA; Singh D; Nair Pananghat A; Lodha R; Kabra SK; Luthra K
Virology; 2016 Dec; 499():105-113. PubMed ID: 27643887
[TBL] [Abstract][Full Text] [Related]
12. Correlation between circulating HIV-1 RNA and broad HIV-1 neutralizing antibody activity.
Sajadi MM; Guan Y; DeVico AL; Seaman MS; Hossain M; Lewis GK; Redfield RR
J Acquir Immune Defic Syndr; 2011 May; 57(1):9-15. PubMed ID: 21283016
[TBL] [Abstract][Full Text] [Related]
13. Characterization of sera from subjects infected with HIV-1 subtypes B and E in Thailand by antibody binding and neutralization.
Louisirirotchanakul S; Beddows S; Cheingsong-Popov R; Shaffer N; Mastro TD; Auewarakul P; Likanonsakul S; Wasi C; Weber J
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):315-20. PubMed ID: 9833739
[TBL] [Abstract][Full Text] [Related]
14. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of HIV subtypes A and D by breast milk IgG from women with HIV infection in Uganda.
Palaia JM; McConnell M; Achenbach JE; Gustafson CE; Stoermer KA; Nolan M; Guay LA; Leitner TK; Matovu F; Taylor AW; Fowler MG; Janoff EN
J Infect; 2014 Mar; 68(3):264-72. PubMed ID: 24239588
[TBL] [Abstract][Full Text] [Related]
16. High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination.
Davis KL; Gray ES; Moore PL; Decker JM; Salomon A; Montefiori DC; Graham BS; Keefer MC; Pinter A; Morris L; Hahn BH; Shaw GM
Virology; 2009 May; 387(2):414-26. PubMed ID: 19298995
[TBL] [Abstract][Full Text] [Related]
17. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
[TBL] [Abstract][Full Text] [Related]
18. VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120.
Smith SA; Burton SL; Kilembe W; Lakhi S; Karita E; Price M; Allen S; Derdeyn CA
Front Immunol; 2018; 9():3163. PubMed ID: 30697215
[TBL] [Abstract][Full Text] [Related]
19. Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170).
McLinden RJ; Paris RM; Polonis VR; Close NC; Su Z; Shikuma CM; Margolis DM; Kim JH
AIDS; 2012 Jan; 26(1):1-9. PubMed ID: 21971356
[TBL] [Abstract][Full Text] [Related]
20. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.
Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C
Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
